NCT04324619 · Milton S. Hershey Medical Center
iLookOut for Child Abuse: Micro-learning to Improve Knowledge Retention
What this study is about
This proposed randomly assigned controlled trial will examine whether gamified micro-learning is a feasible and effective way to promote long-term learning about child abuse and its reporting.
View original scientific description
This proposed randomized controlled trial will examine whether gamified micro-learning is a feasible and effective way to promote long-term learning about child abuse and its reporting. After completing the interactive online learning program, iLookOut for Child Abuse, early childhood professionals will receive brief (5-10 minute) gamified learning exercises to complete on their smart-phones. By measuring knowledge (and other outcomes) over time, the investigators will determine how much knowledge decays over various time periods, how well micro-learning can remediate that decay, and whether such a 2-phase intervention is feasible for helping early childhood professionals be better prepared to identify and report suspected child abuse.
Interventions
OTHER
Online interactive learning activities
1. 3-hour video-storyline-based interactive learning program 2. Micro-learning activities that can be completed on mobile devices (eg, smartphones)
Primary outcome measures
Acceptable completion of iLookOut Micro-learning program measured by 50% of core program learners completing the micro-learning program.
Time frame: 5 years
Evaluate whether a multi-faceted implementation strategy that includes learners completing an initial core training that is reinforced by using a micro-learning program (core learning program + micro-learning) is a way to educate ECPs about child abuse and its reporting. We will judge the iLookOut intervention program to have an acceptable completion rate if: \>50% of ECPs who complete iLookOut's core learning program also complete the micro-learning program.
Feasibility of iLookOut micro-learning program used for professional development measured by 75% of leaner self-reporting learner satisfaction using net promoter score.
Time frame: 5 years
Evaluate whether a multi-faceted implementation strategy that includes learners completing an initial core training followed by using a micro-learning program is a feasible way to educate ECPs about child abuse and its reporting. We will judge the iLookOut intervention feasible if: \>75% of participants report endorsing the iLookOut micro-learning program, as measured by the a net promoter score that is \>0. The net promoter scale consists of one question, How likely would you be to recommend this learning program to a fellow early childhood professional?, with responses measured on a -100 to +100.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- At least 18 years of age
- Works or volunteers at a childcare facility in Pennsylvania
Exclusion criteria
- Younger than 18 years of age
- Does not work or volunteer at a childcare facility in Pennsylvania
Where
- Hershey, Pennsylvania
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 12, 2025 · Source of record for eligibility and locations